1. Lloyd, Sarah E, Rossor, Martin, Fox, Nick, Mead, Simon, Collinge, John. 2009. HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q. In BMC medical genetics, 10, 90. doi:10.1186/1471-2350-10-90. https://pubmed.ncbi.nlm.nih.gov/19754925/
2. Lloyd, Sarah E, Maytham, Emma G, Pota, Hirva, Mead, Simon, Collinge, John. 2009. HECTD2 is associated with susceptibility to mouse and human prion disease. In PLoS genetics, 5, e1000383. doi:10.1371/journal.pgen.1000383. https://pubmed.ncbi.nlm.nih.gov/19214206/
3. Lv, Dong, Xiang, Ying, Song, Tao, Huili, Youlong, Shen, Taimin. 2024. HECTD2 as a target for veratric acid in the regulation of ferroptosis in renal cell carcinoma. In Amino acids, 56, 57. doi:10.1007/s00726-024-03419-0. https://pubmed.ncbi.nlm.nih.gov/39343853/
4. Coon, Tiffany A, McKelvey, Alison C, Lear, Travis, Zhang, Yingze, Chen, Bill B. . The proinflammatory role of HECTD2 in innate immunity and experimental lung injury. In Science translational medicine, 7, 295ra109. doi:10.1126/scitranslmed.aab3881. https://pubmed.ncbi.nlm.nih.gov/26157031/
5. Lv, Dong, Chen, Yongbo, Tang, Liangyou, Jian, Nenghong, Shen, Taimin. . HECTD2/TNFAIP1 Axis Regulating the p38/JNK Pathway to Promote an Inflammatory Response in Renal Cell Carcinoma Cells. In In vivo (Athens, Greece), 38, 1094-1103. doi:10.21873/invivo.13543. https://pubmed.ncbi.nlm.nih.gov/38688591/